Pharmaceutical company Biovitrum gives specialists the treatments they need. Focusing on select diseases treated by specialist physicians, the company makes pharmaceuticals that treat hemophilia and autoimmune diseases like rheumatoid arthritis, scleroderma (hardening of the skin), and others. Its available products include arthritis drug Kineret and cancer side-effect drug Kepivance. The company also has drugs for inflammatory diseases and absorption disorders in development in its pipeline. Biovitrum distributes its products to Europe, Australia, and the US through partnerships with pharmaceutical giants like
See detailed business credit reports on other businesses or your own.
See detailed profiles for insights and prospects on this company's top competitors.
Essential information for a successful call
EMPLOYEES (This Site)
- ASSETS (MIL USD) 5,582
REVENUE (MIL USD)
- TICKER SYMBOL SOBI
- Year Started 1939
- FISCAL YEAR END DEC
- SALES GROWTH % 7.1%
Similar Companies Nearby
Get in Touch with 16 Principals*
Filippa StenbergMember of the Board of Directors
Sven Anders UllmanMember of the Board of Directors
Helena Ildiko SaxonMember of the Board of Directors